SYSTEMIC INFLAMMATION IN ATHEROSCLEROSIS ON THE BACKGROUND OF CHRONIC PERIODONTITIS
Keywords:
coronary heart disease, myocardial infarction, atherosclerosis, C-reactive protein, colchicine.Abstract
Modern data show that in the most effective treatment of atherosclerosis and all diseases of the cardiovascular system, it is necessary to follow 3 basic principles of this disease. These are: control of dyslipidemia, control of hemostasis and control of the inflammatory response[29]. In recent years, attention has increased to colchicine as an anti-inflammatory agent not only in the treatment of gout, but also in the treatment of patients with myocardial infarction and chronic cardiovascular diseases. The anti-inflammatory effect of colchicine is associated with several mechanisms, the main of which is the reduction and elimination of the inflammatory process [30]. In order to increase the effectiveness of treatment for joint diseases and atherosclerosis, the administration of colchicine reduces and eliminates risk factors that can cause diseases.
References
Borgnakke WS, Ylöstalo PV, Taylor GW, et al. Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Clin Periodon-l 2013;40 Suppl 14:S135–52.
Chandan JS, Thomas T, Bradbury-Jones C, et al. Intimate partner violence and temporomandibular joint disorder. J Dent 2019;82:98–100.
Asikainen S, Jousimies-Somer H, Kanervo A, Saxén L. Actinobacillus actinomycetemcomitans and clinical periodontal status in Finnish juvenile periodontitis patients. J Periodontol 1986;57:91-
Chandan JS, Thomas T, Bradbury-Jones C, et al. Female survivors of intimate partner violence and risk of depression, anxiety and serious mental illness. Br J Psychiatry 2020;217:562–
Badimon L, Peña E, Arderiu G, et al. C-Reactive protein in atherothrombosis and angiogenesis. Front Immunol 2018;9:9430–430.
Blak BT, Thompson M, Dattani H, et al. Generalisability of the health improvement network (thin) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 2011;19:251–5.
NHS Digital. Quality and Outcomes Framework (QOF) business rules v42 2019-2020 baseline release - NHS Digital, 2019. Available: https://digital.nhs.uk/data-and-information/data-collections-and- data-sets/data-collections/quality-and-outcomes-framework-qof/ quality-and-outcome-framework-qof-business-rules/quality-and- outcomes-framework-qof-business-rules-v42-2019-2020-baseline- releas [Accessed 31 Jul 2019].
Chandan JS, Keerthy D, Zemedikun DT, et al. The association between exposure - childhood maltreatment and the subsequent development of functional somatic and visceral pain syndromes. EClinicalMedicine 2020;23:100392.
Roca-Millan E, González-Navarro B, Sabater-Recolons M-M, et al. Periodontal treatment on patients with cardiovascular disease: systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 2018;23:e681–90.
Nutalapati R, Kasagani SK, Jampani ND, Mutthineni RB, Chintala S, Kode VS. Comparative evaluation of amoxicillin plus metronidazole and doxycycline alone in the nonsurgical treatment of localized aggressive periodontitis. Indian J Oral Sci 2014;5:112-8.
Teeuw WJ, Slot DE, Susanto H, et al. Treatment of periodontitis improves the atherosclerotic profile: a systematic review and meta- analysis. J Clin Periodontol 2014;41:70–9.
Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363–9.
Lin C-Y, Tseng C-F, Liu J-M, et al. Association between periodontal disease and subsequent sjögren’s syndrome: A nationwide population-based cohort study. Int J Environ Res Public Health 2019;16:771.
Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017;377:1119–31.
Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline. J Clin Periodontol 2020;47 Suppl 22:4–60.
Lafon A, Pereira B, Dufour T, et al. Periodontal disease and stroke: a meta-analysis of cohort studies. Eur J Neurol 2014;21:1155–67.
Orlandi M, Graziani F, D'Aiuto F. Periodontal therapy and cardiovascular risk. Periodontol 2000 2020;83:107–24.
Seitz MW, Listl S, Bar-ls A, et al. Current knowledge on correlations between highly prevalent dental conditions and chronic diseases: an umbrella review. Prev Chronic Dis 2019;16:180641.
Chandan JS, Thomas T, Gokhale KM, et al. The burden of mental ill health associated with childhood maltreatment in the UK, using the health improvement network database: a population-based retrospective cohort study. Lancet Psychiatry 2019;6:926–34.
Fiolet ATL, Silvis MJM, Opstal TSJ, et al. Short-Term effect of low- dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high- sensitivity C-reactive protein. PLoS One 2020;15:e0237665.
Agababyan I.R., Soleeva S.Sh. The place of statins in the complex treatment of SARS-CoV-2. Issues of science and education.. 2021. №14 (139). с.70-80. (in Russ).
Leung Y.Y., Hui L.L., Kraus W.B. Colchicine - update on mechanisms of action and therapeutic applications. Semin Arthritis Rheum 2015; 45: 341-50. (in Russ).
Dalbet N, Lauterio TJ, Wolfe HR. The mechanism of action of colchicine in the treatment of gout. Clin Ther 2014; 36: 1465-79. (in Russ).
Tardif JC, Kuz S, Waters DJ, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 2019; 381: 2497-505.(in Russ).
Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Colchicine in low doses for secondary prevention of cardiovascular diseases. J Am Coll Cardiol 2013; 61: 404-10. (in Russ).
Hemkens LG, Ewald H, Gloy WL, et al. Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis. Heart 2016; 102: 590-6. (in Russ).
28.Araújo MM, Martins CC, Costa LCM, et al. Association between depression and periodontitis: a systematic review and meta-analysis. J Clin Periodon-l 2016;43:216–28.2022). ОЕ ВОСПАЛЕНИЕ КРИЧИННО-СЛЕДСТВ
Rizaev E. A., Agababyan I. R., Arzikulova M. Sh. K. AUTOIMMUNE INFLAMMATION AS A CAUSE-AND-EFFECT RELATIONSHIP OF PERIODONTITIS AND ATHEROSCLEROSIS // Issues of science and education. – 2022. – №. 6 (162). – С. 50-64.(in Russ).
Aghababyan I.R., Ismailov R.M. – RELATIONSHIP OF THE LEVEL OF NEUTROPHILS IN PERIODONTITIS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASES46 NEW DAY MEDICINE-2 (52) 2023.
Alimjanovich, R. J., Sattor o’g’li, N. O., & Mahmayusuf o’g’li, I. R. (2023). DEPENDENCE OF NEUTROPHIL LEVEL ON PERIODONTAL CONDITION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE. (LITERARY REVIEW).JOURNAL OF BIOMEDICINE AND PRACTICE, 8(1). (in Russ).
Rizaev , Zh. A., Aghababyan , I. R., Yarasheva , Z. Kh., & Mukhamedova , M. G. (2022). The importance of comorbid conditions in the development of chronic heart failure in elderly and senile patients. Achievements of science and education, (1 (81)), 75-79.
JA Rizaev , I. R. Agababyan , YAIsmoilova ACTIVITIES OF CLINICS
